NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)Rizwan Romee, Jeffrey S. Miller, Bree Foley et al.|Blood|2013Cited by 537
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantationRizwan Romee, Jeffrey S. Miller, Sarah Cooley et al.|Blood|2018Cited by 406
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AMLAndreas T. Björklund, Karl‐Johan Malmberg, Mattias Carlsten et al.|Clinical Cancer Research|2018Cited by 195
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapyKarrune Woan, Frank Cichocki, Yenan T. Bryceson et al.|Cell stem cell|2021Cited by 153
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myelomaFrank Cichocki, Jeffrey S. Miller|Nature Communications|2022Cited by 73